Adherence to guidelines for antithrombotic therapy in patients with atrial fibrillation according to CHADS2 score before and after stroke: A multicenter observational study from Korea

Journal of Clinical Neurology (Korea)

Volumn 12, Issue 1, 2016, Pages 34-41

  Kim, Wook Joo ^a   Park, Jong Moo ^b   Kang, Kyusik ^b   Cho, Yong Jin ^c   Hong, Keun Sik ^c   Lee, Soo Joo ^d   Ko, Youngchai ^d   Lee, Kyung Bok ^e   Park, Tai Hwan ^f   Lee, Jun ^g   Cha, Jae Kwan ^h   Kim, Dae Hyun ^h   Yu, Kyung Ho ⁱ   Lee, Byung Chul ⁱ   Oh, Mi Sun ⁱ   Lee, Juneyoung ^j   Lee, Jisung ^k   Jang, Myung Suk ^l   Han, Moon Ku ^l   Bae, Hee Joon ^l  

^a University of Ulsan College of Medicine   (South Korea)

^b Eulji General Hospital   (South Korea)

^c Inje University   (South Korea)

^d Eulji University   (South Korea)

^e Soonchunhyang University College of Medicine   (South Korea)

^f Seoul Medical Center   (South Korea)

^g Young Nam University Hospital   (South Korea)

^h Dong A University   (South Korea)

ⁱ Hallym University College of Medicine   (South Korea)

^j Korea University College of Medicine   (South Korea)

^k Asan Medical Center   (South Korea)

^l Seoul National University Bundang Hospital   (South Korea)

more..

Author keywords

Atrial fibrillation; Cerebral infarction; Drug utilization review; Guideline adherence

Indexed keywords

EID: 84954319094     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2016.12.1.34     Document Type: Article

References (30)

1. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263-272.
2. Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):546S-592S.
3. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guide- lines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in col- laboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-e354.
4. Clinical Research Center for Stroke. Clinical Practice Guidelines for Stroke. Revision. Seoul: Clinical Research Center for Stroke, 2013. Available from: http://www.stroke.or.kr/image/CPGStrok (English) 20130730.pdf
5. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturve- di S, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:517-584.
6. ACTIVE Writing Group of the ACTIVE Investigators, Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, et al. Clopidogrel plus aspi- rin versus oral anticoagulation for atrial fibrillation in the Atrial fi- brillation Clopidogrel Trial with Irbesartan for prevention of Vascu- lar Events (ACTIVE W): a randomised controlled trial. Lancet 2006; 367:1903-1912.
7. van Walraven C, Hart RG, Singer DE, Laupacis A, Connolly S, Pe- tersen P, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002;288:2441-2448.
8. van Walraven C, Hart RG, Connolly S, Austin PC, Mant J, Hobbs FD, et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators. Stroke 2009;40: 1410-1416.
9. Kowey PR, Reiffel JA, Myerburg R, Naccarelli GV, Packer DL, Pratt CM, et al. Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry). Am J Cardiol 2010; 105:1130-1134.
10. Friberg L, Hammar N, Ringh M, Pettersson H, Rosenqvist M. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF- study). Eur Heart J 2006;27:1954-1964.
11. Monte S, Macchia A, Pellegrini F, Romero M, Lepore V, D’Ettorre A, et al. Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation. Eur Heart J 2006;27:2217-2223.
12. Hylek EM, DAntonio J, Evans-Molina C, Shea C, Henault LE, Regan S. Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly pa- tients with atrial fibrillation. Stroke 2006;37:1075-1080.
13. Gladstone DJ, Bui E, Fang J, Laupacis A, Lindsay MP, Tu JV, et al. Potentially preventable strokes in high-risk patients with atrial fibrilla- tion who are not adequately anticoagulated. Stroke 2009;40:235-240.
14. Schwammenthal Y, Bornstein NM, Goldbourt U, Koton S, Schwartz R, Koren-Morag N, et al. Anticoagulation remains underused in pre- vention of stroke associated with atrial fibrillation: insights from two consecutive national surveys. Int J Cardiol 2011;152:356-361.
15. Kim BJ, Han MK, Park TH, Park SS, Lee KB, Lee BC, et al. Current status of acute stroke management in Korea: a report on a multicenter, comprehensive acute stroke registry. Int J Stroke 2014;9:514-518.
16. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285:2864-2870.
17. Hart RG, Pearce LA. Current status of stroke risk stratification in pa- tients with atrial fibrillation. Stroke 2009;40:2607-2610.
18. Ahmad O, Ahmad KE, Dear KB, Harvey I, Hughes A, Lueck CJ. Atrial fibrillation and anticoagulation in a stroke unit population. In- tern Med J 2009;39:752-756.
19. Gandolfo C, Balestrino M, Burrone A, Del Sette M, Finocchi C. Stroke due to atrial fibrillation and the attitude to prescribing anticoagulant prevention in Italy. A prospective study of a consecutive stroke popu- lation admitted to a comprehensive stroke unit. J Neurol 2008;255: 796-802.
20. Sun MC, Hsiao PJ. In-hospital case management to increase antico- agulation therapy for stroke patients with atrial fibrillation: a hospital-based registry. J Formos Med Assoc 2013;112:263-268.
21. Lopes RD, Shah BR, Olson DM, Zhao X, Pan W, Bushnell CD, et al.
22. Srivastava A, Hudson M, Hamoud I, Cavalcante J, Pai C, Kaatz S. Examining warfarin underutilization rates in patients with atrial fibrillation: detailed chart review essential to capture contraindications to warfarin therapy. Thromb J 2008;6:6.
23. Meiltz A, Zimmermann M, Urban P, Bloch A Association of Cardi- ologists of the Canton of Geneva. Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guide- lines in the real world. Europace 2008;10:674-680.
24. Nieuwlaat R, Capucci A, Lip GY, Olsson SB, Prins MH, Nieman FH, et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2006;27:3018-3026.
25. Atarashi H, Inoue H, Okumura K, Yamashita T, Kumagai N, Origasa H; J-RHYTHM Registry Investigators. Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry. Circ J 2011;75:1328-1333.
26. Barnes GD, Kaatz S, Winfield J, Gu X, Haymart B, Kline-Rogers E, et al. Warfarin use in atrial fibrillation patients at low risk for stroke: analysis of the Michigan Anticoagulation Quality Improvement Ini- tiative [MAQI (2)]. J Thromb Thrombolysis 2014;37:171-176.
27. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiolo- gy Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011;123:e269-e367.
28. Partington SL, Abid S, Teo K, Oczkowski W, O’Donnell MJ. Pre-ad- mission warfarin use in patients with acute ischemic stroke and atrial fibrillation: the appropriate use and barriers to oral anticoagulant therapy. Thromb Res 2007;120:663-669.
29. Deplanque D, Leys D, Parnetti L, Schmidt R, Ferro J, de Reuck J, et al. Secondary prevention of stroke in patients with atrial fibrillation: factors influencing the prescription of oral anticoagulation at dis- charge. Cerebrovasc Dis 2006;21:372-379.
30. You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e531S-e575S.